Article citationsMore>>

Preiss, D., Tikkanen, M.J., Welsh, P., Ford, I., Lovato, L.C., et al. (2012) Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-Analysis. The Journal of the American Medical Association, 308, 804-811.
https://doi.org/10.1001/jama.2012.8439

has been cited by the following article:

• TITLE: When the Stars Align: Hypertriglyceridemic Pancreatitis Is Inevitable

  AUTHORS: Kamel El-Reshaid, Abass Hakim, Reji Philip Athyal

  KEYWORDS: Fenofibrate, Genetic Hypertriglyceridemia, Hyperlipidemia, Pancreatitis, Triggers, Weight Reduction

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.15 No.7, July 19, 2024

  ABSTRACT: Background: Acute pancreatitis (AP) is an inflammatory process affecting the pancreas. Hypertriglyceridemic AP (HTAP) is its third leading cause after gallstones followed by alcohol use. It develops when stars align viz. triggers (acquired surges) in patients with genetic hypertriglyceridemia. Case: severe and acute pancreatitis had developed in a 57-year-old man with type IIb familial hyperlipidemia after heavy fatty meals. The acute phase was controlled by holding oral intake with weekly Evolocumab therapy and long-term prevention by weight reduction and Fenofibrate alone. His pancreatic endocrine and exocrine functions remained normal after 2 years of follow-up. Conclusion: Those four measures were safe, practical and effective for short- and long-term management of HTAP.